Tag: Blood Banks

  • Hepatitis C Testing Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Hepatitis C Testing Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Hepatitis C Testing Market Value Growth And Long-Term Outlook

    The hepatitis c testing market has experienced robust expansion in recent years. Forecasts indicate an increase from $1.32 billion in 2025 to $1.4 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. Historically, this growth has stemmed from factors such as broader blood screening programs, an increase in hepatitis C infection rates, heightened awareness regarding diagnostics, the availability of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is projected to experience robust expansion over the coming years, anticipated to reach $1.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is primarily driven by escalating global elimination initiatives, a rising demand for point-of-care diagnostics, wider access to molecular testing, increasing investments in infectious disease diagnostics, and a heightened emphasis on early intervention. Significant trends throughout this period include the increasing adoption of rapid diagnostic tests, more widespread application of molecular testing technologies, a growing focus on early disease screening, the expansion of high-throughput laboratory testing, and enhanced monitoring of treatment outcomes.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=87652020&type=smp&name=Hepatitis%20C%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

    Hepatitis C Testing Market Development Factors: What’s Supporting Demand?

    The increasing occurrence of hepatitis infections is anticipated to boost the expansion of the hepatitis C testing market moving ahead. Hepatitis C is a viral infection that causes liver inflammation and can lead to significant liver damage if not addressed. The rise in hepatitis cases primarily stems from insufficient vaccination rates, which leave many individuals vulnerable and facilitate the virus’s transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and severe complications. Furthermore, it helps identify infected individuals, aiding in preventing further spread and improving disease management. For instance, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for global public health, over 50 million people are living with chronic hepatitis C virus infection globally, with approximately 1.0 million new infections occurring each year. Therefore, the growing incidence of hepatitis cases is stimulating the development of the hepatitis C testing market.

    Hepatitis C Testing Market Segment Landscape: Which Areas Lead Development?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    Hepatitis C Testing Market Trends Powering Strategic Industry Growth

    Leading companies within the hepatitis C testing market are concentrating on developing sophisticated solutions, including dual antigen-antibody diagnostic tests, to facilitate more efficient screening and monitoring of the infection. An antigen-antibody diagnostic test identifies viral proteins (antigens) and immune response proteins (antibodies), making it possible to detect both active and past infections. This combined strategy provides a thorough evaluation of the infection status. For instance, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay designed to simultaneously and independently detect both HCV antigens and antibodies from a single plasma or serum sample. This advancement supports early diagnosis, assists in patient management, and corresponds with India’s national initiative to eliminate hepatitis C through prompt and exhaustive screening.

    Hepatitis C Testing Market Industry Leaders And Competitive Landscape

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    View The Full Hepatitis C Testing Market Report:

    https://thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

    Hepatitis C Testing Market Top Region By Revenue And Market Share

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Growth Outlook Reveals A CAGR Of 6.1% And A Market Value Of $1.77 Billion By 2030

    Hepatitis C Testing Market Growth Outlook Reveals A CAGR Of 6.1% And A Market Value Of $1.77 Billion By 2030

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Hepatitis C Testing Market Size, Value And Growth Trends Through 2030

    The market for hepatitis C testing experienced robust expansion recently, projected to increase from $1.32 billion in 2025 to $1.4 billion in 2026, reflecting a compound annual growth rate of 6.4%. This historical growth trajectory was bolstered by factors such as the broadening of blood screening initiatives, an increasing incidence of hepatitis C infections, heightened awareness regarding diagnostics, the accessibility of sophisticated testing kits, and the proliferation of public health monitoring efforts.

    Anticipated to experience considerable expansion over the coming years, the hepatitis C testing market’s valuation is projected to reach $1.78 billion by 2030, fueled by a compound annual growth rate of 6.1%. This upward trajectory throughout the forecast period is demonstrably linked to escalating worldwide efforts for hepatitis C elimination, a surge in the requirement for diagnostics administered at the point of care, broader accessibility to molecular testing methodologies, augmented financial commitments towards infectious disease diagnostics, and a heightened emphasis on initiating treatment promptly. Key developments anticipated within this timeframe encompass the increased integration of rapid diagnostic tools, a greater reliance on molecular testing technologies, a more pronounced concentration on early disease detection through screening, the proliferation of high-volume laboratory testing capabilities, and more sophisticated methods for tracking the efficacy of therapeutic interventions.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    Hepatitis C Testing Market Growth Factors: Which Forces Are Supporting Market Expansion?

    Anticipated growth in the hepatitis C testing market is being spurred by an increasing incidence of hepatitis cases. This viral infection, hepatitis C, targets the liver, causing inflammation and potentially severe harm if untreated. A significant factor contributing to the rise in hepatitis infections is the inadequacy of vaccination coverage, leaving substantial portions of the population vulnerable and enabling wider transmission of the virus. Early identification through hepatitis C testing is crucial for initiating timely treatment, thereby preventing liver damage and mitigating severe health consequences. Furthermore, it aids in identifying infected persons, which is instrumental in curbing the onward transmission and improving overall disease management strategies. Specifically, as of April 2024, the World Health Organization, a global health authority headquartered in Switzerland, reported that more than 50 million individuals worldwide are affected by chronic hepatitis C, with an estimated 1 million new cases emerging annually. Consequently, the escalating number of hepatitis cases is a key driver for the expansion of the hepatitis C testing market.

    Hepatitis C Testing Market Segment Landscape: Which Areas Lead Market Development?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    Hepatitis C Testing Market Industry Trends: What Changes Are Reshaping Demand?

    In the hepatitis C testing arena, leading enterprises are prioritizing the creation of sophisticated diagnostic tools, exemplified by dual antigen-antibody assays, to enhance the efficacy of both infection detection and ongoing patient management. These advanced tests are designed to identify viral proteins alongside the body’s defensive proteins, thus providing a comprehensive assessment of current and prior hepatitis C exposure. A prime illustration of this technological progression came in July 2023 when Roche Diagnostics India Pvt. Ltd., a prominent Indian entity in the diagnostics sector, introduced Elecsys HCV Duo. This automated immunoassay system possesses the unique capability to concurrently and distinctly identify both hepatitis C antigens and antibodies from a single patient sample, whether plasma or serum. Such a development facilitates earlier disease identification, aids in the effective management of individuals affected by the virus, and directly supports India’s national objective of eradicating hepatitis C by ensuring prompt and exhaustive screening protocols.

    Hepatitis C Testing Market Industry Leaders And Market Competition

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Hepatitis C Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    Hepatitis C Testing Market Regional Outlook: Where Are The Largest Opportunities Located?

    North Americawas the largest region in the hepatitis C testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Outlook: Key Drivers and Market Evolution

    Hepatitis C Testing Market Outlook: Key Drivers and Market Evolution

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Does The Market Size Of The Hepatitis C Testing Market Compare Between 2026 And 2030?

    The hepatitis c testing market size has shown significant growth in recent years. It is projected to expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The increase observed historically can be attributed to the expansion of blood screening programs, the rising prevalence of hepatitis c infections, improved diagnostic awareness, the availability of advanced testing kits, and growth in public health surveillance initiatives.

    The hepatitis C testing market is set to experience significant expansion in the upcoming years. It is predicted to reach a value of $1.78 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.1%. This projected growth stems from factors such as increasing global initiatives for elimination, a heightened demand for point-of-care diagnostics, broader access to molecular testing, rising investments in infectious disease diagnostics, and a greater emphasis on early intervention. Prominent trends anticipated during the forecast period include a surge in the adoption of rapid diagnostic tests, expanding use of molecular testing technologies, a stronger focus on early disease screening, the broadening of high-throughput laboratory testing, and enhanced monitoring of treatment outcomes.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    What Key Factors Are Affecting The Hepatitis C Testing Market Demand?

    The increasing incidence of hepatitis cases is projected to boost the expansion of the hepatitis C testing market moving forward. Hepatitis C is a viral infection causing liver inflammation, which can lead to significant liver damage if left unaddressed. The rise in hepatitis cases is primarily due to low vaccination rates, leaving many individuals susceptible and accelerating the virus’s transmission. Hepatitis C testing facilitates early virus identification, allowing for prompt treatment to prevent liver damage and severe complications. It also helps identify infected individuals, assisting in preventing further spread and improving disease control. For example, in April 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental body focused on global public health, reported that over 50 million people worldwide live with chronic hepatitis C virus infection, with approximately 1.0 million new infections occurring each year. Thus, the growing prevalence of hepatitis cases is a key driver for the hepatitis C testing market.

    What Are The Different Segment Types In The Hepatitis C Testing Market Segment Breakdown?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Influencing Changes In The Hepatitis C Testing Market?

    Leading companies in the hepatitis C testing market are concentrating on developing advanced solutions, such as dual antigen-antibody diagnostic tests, to achieve more effective infection screening and monitoring. These diagnostic tests pinpoint both viral proteins (antigens) and immune response proteins (antibodies), allowing for the identification of both current and prior infections. This dual method provides a comprehensive assessment of the infection’s status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay offers the capability to detect both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This advancement supports early diagnosis, assists in patient management, and contributes to India’s national strategy to eliminate hepatitis C through timely and thorough screening.

    Who Are The Well-Known Companies In The Hepatitis C Testing Market?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Get The Full Hepatitis C Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    Which Region Holds The Highest Market Share In The Hepatitis C Testing Market?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Hepatitis C Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Hepatitis C Testing Industry Trends and Market Growth Forecast for 2026–2030

    Global Hepatitis C Testing Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Large Is The Hepatitis C Testing Market Projected To Become By 2030 Based On Its 2026 Valuation?

    The hepatitis c testing market has experienced strong growth in recent years. It is projected to expand from $1.32 billion in 2025 to reach $1.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. The historical growth of this market can be attributed to the expansion of blood screening programs, an increasing prevalence of hepatitis c infections, improved diagnostic awareness, the availability of advanced testing kits, and the growth in public health surveillance initiatives.

    The hepatitis C testing market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $1.78 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the forecast period include the surge in global elimination programs, a heightened need for point-of-care diagnostic solutions, wider availability of molecular testing, increased funding for infectious disease diagnostics, and an intensified emphasis on prompt intervention. Key trends observed within the forecast timeframe encompass the wider embrace of rapid diagnostic tests, an escalating reliance on molecular testing technologies, a concentrated effort towards early disease detection, the broadening scope of high-throughput laboratory testing, and improved oversight of treatment results.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Primary Drivers Are Shaping The Development Of The Hepatitis C Testing Market?

    The increasing incidence of hepatitis cases is anticipated to drive expansion in the hepatitis C testing market moving ahead. Hepatitis C, a viral infection, inflames the liver and can result in severe liver damage if not addressed. The surge in hepatitis cases primarily stems from low vaccination coverage, which leaves many vulnerable and promotes the virus’s dissemination. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and significant complications. Furthermore, it identifies infected people, aiding in preventing its transmission and improving disease management. For instance, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for global public health, over 50 million individuals globally are living with chronic hepatitis C virus infection, with approximately 1.0 million new infections arising each year. Consequently, the growing occurrence of hepatitis cases is a key factor propelling the expansion of the hepatitis C testing market.

    What Segment Groups Are Identified Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    Which Trends Are Influencing The Hepatitis C Testing Market?

    Prominent companies operating in the hepatitis C testing market are concentrating on creating advanced solutions, including dual antigen-antibody diagnostic tests, to facilitate more efficient screening and oversight of the infection. This diagnostic method identifies both viral proteins (antigens) and immune response proteins (antibodies), allowing for the detection of active and prior infections. This combined strategy provides a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay can simultaneously and independently detect both HCV antigens and antibodies from a single plasma or serum sample. This advancement supports early diagnosis, aids patient management, and aligns with India’s national goal to eliminate hepatitis C through timely and thorough screening.

    Which Companies Hold Significant Positions In The Hepatitis C Testing Market?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Read the full hepatitis c testing market report here:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Hepatitis C Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Hepatitis Diagnostic Tests Global Market Report

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Global Market Report

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Viral Hepatitis Global Market Report

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

    The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

    The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

    The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

    What Segments Are Included Within The Hepatitis C Testing Market?

    The hepatitis c testing market covered in this report is segmented –

    1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

    2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

    3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

    4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

    Subsegments:

    1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

    2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

    What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

    Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

    Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

    Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

    How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

    North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

    Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

    Viral Hepatitis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

    Hepatitis Diagnostic Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

    Covid 19 Rapid Test Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model